カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

中枢神経系用治療薬の世界市場2025年：OTC、Rxドラッグ

■ 英語タイトル：Global Central Nervous System Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3772）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3772
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[中枢神経系用治療薬の世界市場2025年：OTC、Rxドラッグ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の中枢神経系用治療薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の中枢神経系用治療薬の市場規模は2024年のxxx米ドルから2031年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

中枢神経系用治療薬市場はタイプとアプリケーションによって区分されます。2020年～2031年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・OTC、Rxドラッグ

アプリケーション別セグメントは次のように区分されます。
・病院、薬局

世界の中枢神経系用治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Biogen、Pfizer、Teva、Novartis、Johnson & Johnson、EliLilly、Otsuka、Merck、AstraZeneca、Novartis、Takeda

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、中枢神経系用治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な中枢神経系用治療薬メーカーの企業概要、2022年～2024年までの中枢神経系用治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な中枢神経系用治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2020年～2031年までの地域別中枢神経系用治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2020年～2031年までの中枢神経系用治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2020年～2024年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での中枢神経系用治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および中枢神経系用治療薬の産業チェーンを掲載しています。
・第13、14、15章では、中枢神経系用治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 中枢神経系用治療薬の概要
– 種類別分析（2020年vs2024年vs2031年）：OTC、Rxドラッグ
– 用途別分析（2020年vs2024年vs2031年）：病院、薬局
– 世界の中枢神経系用治療薬市場規模・予測
– 世界の中枢神経系用治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Biogen、Pfizer、Teva、Novartis、Johnson & Johnson、EliLilly、Otsuka、Merck、AstraZeneca、Novartis、Takeda
・メーカー別市場シェア・市場集中度
・地域別市場分析2020年-2031年
・種類別分析2020年-2031年：OTC、Rxドラッグ
・用途別分析2020年-2031年：病院、薬局
・中枢神経系用治療薬の北米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・中枢神経系用治療薬のヨーロッパ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・中枢神経系用治療薬のアジア市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・中枢神経系用治療薬の南米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・中枢神経系用治療薬の中東・アフリカ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Central Nervous System Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Central Nervous System Drugs Revenue by Type: 2020 Versus 2024 Versus 2031
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Central Nervous System Drugs Revenue by Application: 2020 Versus 2024 Versus 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Central Nervous System Drugs Market Size & Forecast
1.4.1 Global Central Nervous System Drugs Sales in Value (2020 & 2024 & 2031)
1.4.2 Global Central Nervous System Drugs Sales in Volume (2020-2031)
1.4.3 Global Central Nervous System Drugs Price (2020-2031)
1.5 Global Central Nervous System Drugs Production Capacity Analysis
1.5.1 Global Central Nervous System Drugs Total Production Capacity (2020-2031)
1.5.2 Global Central Nervous System Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Central Nervous System Drugs Market Drivers
1.6.2 Central Nervous System Drugs Market Restraints
1.6.3 Central Nervous System Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Central Nervous System Drugs Product and Services
2.1.4 Biogen Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Central Nervous System Drugs Product and Services
2.2.4 Pfizer Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Central Nervous System Drugs Product and Services
2.3.4 Teva Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Central Nervous System Drugs Product and Services
2.4.4 Novartis Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Central Nervous System Drugs Product and Services
2.5.4 Johnson & Johnson Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.6 EliLilly
2.6.1 EliLilly Details
2.6.2 EliLilly Major Business
2.6.3 EliLilly Central Nervous System Drugs Product and Services
2.6.4 EliLilly Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.7 Otsuka
2.7.1 Otsuka Details
2.7.2 Otsuka Major Business
2.7.3 Otsuka Central Nervous System Drugs Product and Services
2.7.4 Otsuka Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Central Nervous System Drugs Product and Services
2.8.4 Merck Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Central Nervous System Drugs Product and Services
2.9.4 AstraZeneca Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Central Nervous System Drugs Product and Services
2.10.4 Novartis Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.11 Takeda
2.11.1 Takeda Details
2.11.2 Takeda Major Business
2.11.3 Takeda Central Nervous System Drugs Product and Services
2.11.4 Takeda Central Nervous System Drugs Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
3 Central Nervous System Drugs Breakdown Data by Manufacturer
3.1 Global Central Nervous System Drugs Sales in Volume by Manufacturer (2021, 2022, 2023, and 2024)
3.2 Global Central Nervous System Drugs Revenue by Manufacturer (2021, 2022, 2023, and 2024)
3.3 Key Manufacturer Market Position in Central Nervous System Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Central Nervous System Drugs Manufacturer Market Share in 2024
3.4.2 Top 6 Central Nervous System Drugs Manufacturer Market Share in 2024
3.5 Global Central Nervous System Drugs Production Capacity by Company: 2023 VS 2024
3.6 Manufacturer by Geography: Head Office and Central Nervous System Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Central Nervous System Drugs Market Size by Region
4.1.1 Global Central Nervous System Drugs Sales in Volume by Region (2020-2031)
4.1.2 Global Central Nervous System Drugs Revenue by Region (2020-2031)
4.2 North America Central Nervous System Drugs Revenue (2020-2031)
4.3 Europe Central Nervous System Drugs Revenue (2020-2031)
4.4 Asia-Pacific Central Nervous System Drugs Revenue (2020-2031)
4.5 South America Central Nervous System Drugs Revenue (2020-2031)
4.6 Middle East and Africa Central Nervous System Drugs Revenue (2020-2031)
5 Market Segment by Type
5.1 Global Central Nervous System Drugs Sales in Volume by Type (2020-2031)
5.2 Global Central Nervous System Drugs Revenue by Type (2020-2031)
5.3 Global Central Nervous System Drugs Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Central Nervous System Drugs Sales in Volume by Application (2020-2031)
6.2 Global Central Nervous System Drugs Revenue by Application (2020-2031)
6.3 Global Central Nervous System Drugs Price by Application (2020-2031)
7 North America by Country, by Type, and by Application
7.1 North America Central Nervous System Drugs Sales by Type (2020-2031)
7.2 North America Central Nervous System Drugs Sales by Application (2020-2031)
7.3 North America Central Nervous System Drugs Market Size by Country
7.3.1 North America Central Nervous System Drugs Sales in Volume by Country (2020-2031)
7.3.2 North America Central Nervous System Drugs Revenue by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe by Country, by Type, and by Application
8.1 Europe Central Nervous System Drugs Sales by Type (2020-2031)
8.2 Europe Central Nervous System Drugs Sales by Application (2020-2031)
8.3 Europe Central Nervous System Drugs Market Size by Country
8.3.1 Europe Central Nervous System Drugs Sales in Volume by Country (2020-2031)
8.3.2 Europe Central Nervous System Drugs Revenue by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Central Nervous System Drugs Sales by Type (2020-2031)
9.2 Asia-Pacific Central Nervous System Drugs Sales by Application (2020-2031)
9.3 Asia-Pacific Central Nervous System Drugs Market Size by Region
9.3.1 Asia-Pacific Central Nervous System Drugs Sales in Volume by Region (2020-2031)
9.3.2 Asia-Pacific Central Nervous System Drugs Revenue by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America by Region, by Type, and by Application
10.1 South America Central Nervous System Drugs Sales by Type (2020-2031)
10.2 South America Central Nervous System Drugs Sales by Application (2020-2031)
10.3 South America Central Nervous System Drugs Market Size by Country
10.3.1 South America Central Nervous System Drugs Sales in Volume by Country (2020-2031)
10.3.2 South America Central Nervous System Drugs Revenue by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Central Nervous System Drugs Sales by Type (2020-2031)
11.2 Middle East & Africa Central Nervous System Drugs Sales by Application (2020-2031)
11.3 Middle East & Africa Central Nervous System Drugs Market Size by Country
11.3.1 Middle East & Africa Central Nervous System Drugs Sales in Volume by Country (2020-2031)
11.3.2 Middle East & Africa Central Nervous System Drugs Revenue by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Raw Material and Industry Chain
12.1 Raw Material of Central Nervous System Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Central Nervous System Drugs
12.3 Central Nervous System Drugs Production Process
12.4 Central Nervous System Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Central Nervous System Drugs Typical Distributors
13.3 Central Nervous System Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Central Nervous System Drugs Revenue by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Central Nervous System Drugs Revenue by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Biogen Basic Information, Manufacturing Base and Competitors
Table 4. Biogen Major Business
Table 5. Biogen Central Nervous System Drugs Product and Services
Table 6. Biogen Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Central Nervous System Drugs Product and Services
Table 10. Pfizer Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Central Nervous System Drugs Product and Services
Table 14. Teva Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Central Nervous System Drugs Product and Services
Table 18. Novartis Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Central Nervous System Drugs Product and Services
Table 22. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 23. EliLilly Basic Information, Manufacturing Base and Competitors
Table 24. EliLilly Major Business
Table 25. EliLilly Central Nervous System Drugs Product and Services
Table 26. EliLilly Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 27. Otsuka Basic Information, Manufacturing Base and Competitors
Table 28. Otsuka Major Business
Table 29. Otsuka Central Nervous System Drugs Product and Services
Table 30. Otsuka Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Central Nervous System Drugs Product and Services
Table 34. Merck Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 35. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca Major Business
Table 37. AstraZeneca Central Nervous System Drugs Product and Services
Table 38. AstraZeneca Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis Central Nervous System Drugs Product and Services
Table 42. Novartis Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 43. Takeda Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Major Business
Table 45. Takeda Central Nervous System Drugs Product and Services
Table 46. Takeda Central Nervous System Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 47. Global Central Nervous System Drugs Sales by Manufacturer (2021, 2022, 2023, and 2024) & (K Units)
Table 48. Global Central Nervous System Drugs Revenue by Manufacturer (2021, 2022, 2023, and 2024) & (USD Million)
Table 49. Market Position of Manufacturers in Central Nervous System Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 50. Global Central Nervous System Drugs Production Capacity by Company, (K Units): 2023 VS 2024
Table 51. Head Office and Central Nervous System Drugs Production Site of Key Manufacturer
Table 52. Central Nervous System Drugs New Entrant and Capacity Expansion Plans
Table 53. Central Nervous System Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Central Nervous System Drugs Sales by Region (2020-2024) & (K Units)
Table 55. Global Central Nervous System Drugs Sales by Region (2025-2031) & (K Units)
Table 56. Global Central Nervous System Drugs Revenue by Region (2020-2024) & (USD Million)
Table 57. Global Central Nervous System Drugs Revenue by Region (2025-2031) & (USD Million)
Table 58. Global Central Nervous System Drugs Sales by Type (2020-2024) & (K Units)
Table 59. Global Central Nervous System Drugs Sales by Type (2025-2031) & (K Units)
Table 60. Global Central Nervous System Drugs Revenue by Type (2020-2024) & (USD Million)
Table 61. Global Central Nervous System Drugs Revenue by Type (2025-2031) & (USD Million)
Table 62. Global Central Nervous System Drugs Price by Type (2020-2024) & (USD/Unit)
Table 63. Global Central Nervous System Drugs Price by Type (2025-2031) & (USD/Unit)
Table 64. Global Central Nervous System Drugs Sales by Application (2020-2024) & (K Units)
Table 65. Global Central Nervous System Drugs Sales by Application (2025-2031) & (K Units)
Table 66. Global Central Nervous System Drugs Revenue by Application (2020-2024) & (USD Million)
Table 67. Global Central Nervous System Drugs Revenue by Application (2025-2031) & (USD Million)
Table 68. Global Central Nervous System Drugs Price by Application (2020-2024) & (USD/Unit)
Table 69. Global Central Nervous System Drugs Price by Application (2025-2031) & (USD/Unit)
Table 70. North America Central Nervous System Drugs Sales by Country (2020-2024) & (K Units)
Table 71. North America Central Nervous System Drugs Sales by Country (2025-2031) & (K Units)
Table 72. North America Central Nervous System Drugs Revenue by Country (2020-2024) & (USD Million)
Table 73. North America Central Nervous System Drugs Revenue by Country (2025-2031) & (USD Million)
Table 74. North America Central Nervous System Drugs Sales by Type (2020-2024) & (K Units)
Table 75. North America Central Nervous System Drugs Sales by Type (2025-2031) & (K Units)
Table 76. North America Central Nervous System Drugs Sales by Application (2020-2024) & (K Units)
Table 77. North America Central Nervous System Drugs Sales by Application (2025-2031) & (K Units)
Table 78. Europe Central Nervous System Drugs Sales by Country (2020-2024) & (K Units)
Table 79. Europe Central Nervous System Drugs Sales by Country (2025-2031) & (K Units)
Table 80. Europe Central Nervous System Drugs Revenue by Country (2020-2024) & (USD Million)
Table 81. Europe Central Nervous System Drugs Revenue by Country (2025-2031) & (USD Million)
Table 82. Europe Central Nervous System Drugs Sales by Type (2020-2024) & (K Units)
Table 83. Europe Central Nervous System Drugs Sales by Type (2025-2031) & (K Units)
Table 84. Europe Central Nervous System Drugs Sales by Application (2020-2024) & (K Units)
Table 85. Europe Central Nervous System Drugs Sales by Application (2025-2031) & (K Units)
Table 86. Asia-Pacific Central Nervous System Drugs Sales by Region (2020-2024) & (K Units)
Table 87. Asia-Pacific Central Nervous System Drugs Sales by Region (2025-2031) & (K Units)
Table 88. Asia-Pacific Central Nervous System Drugs Revenue by Region (2020-2024) & (USD Million)
Table 89. Asia-Pacific Central Nervous System Drugs Revenue by Region (2025-2031) & (USD Million)
Table 90. Asia-Pacific Central Nervous System Drugs Sales by Type (2020-2024) & (K Units)
Table 91. Asia-Pacific Central Nervous System Drugs Sales by Type (2025-2031) & (K Units)
Table 92. Asia-Pacific Central Nervous System Drugs Sales by Application (2020-2024) & (K Units)
Table 93. Asia-Pacific Central Nervous System Drugs Sales by Application (2025-2031) & (K Units)
Table 94. South America Central Nervous System Drugs Sales by Country (2020-2024) & (K Units)
Table 95. South America Central Nervous System Drugs Sales by Country (2025-2031) & (K Units)
Table 96. South America Central Nervous System Drugs Revenue by Country (2020-2024) & (USD Million)
Table 97. South America Central Nervous System Drugs Revenue by Country (2025-2031) & (USD Million)
Table 98. South America Central Nervous System Drugs Sales by Type (2020-2024) & (K Units)
Table 99. South America Central Nervous System Drugs Sales by Type (2025-2031) & (K Units)
Table 100. South America Central Nervous System Drugs Sales by Application (2020-2024) & (K Units)
Table 101. South America Central Nervous System Drugs Sales by Application (2025-2031) & (K Units)
Table 102. Middle East & Africa Central Nervous System Drugs Sales by Region (2020-2024) & (K Units)
Table 103. Middle East & Africa Central Nervous System Drugs Sales by Region (2025-2031) & (K Units)
Table 104. Middle East & Africa Central Nervous System Drugs Revenue by Region (2020-2024) & (USD Million)
Table 105. Middle East & Africa Central Nervous System Drugs Revenue by Region (2025-2031) & (USD Million)
Table 106. Middle East & Africa Central Nervous System Drugs Sales by Type (2020-2024) & (K Units)
Table 107. Middle East & Africa Central Nervous System Drugs Sales by Type (2025-2031) & (K Units)
Table 108. Middle East & Africa Central Nervous System Drugs Sales by Application (2020-2024) & (K Units)
Table 109. Middle East & Africa Central Nervous System Drugs Sales by Application (2025-2031) & (K Units)
Table 110. Central Nervous System Drugs Raw Material
Table 111. Key Manufacturers of Central Nervous System Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Central Nervous System Drugs Typical Distributors
Table 115. Central Nervous System Drugs Typical Customers
List of Figures
Figure 1. Central Nervous System Drugs Picture
Figure 2. Global Central Nervous System Drugs Revenue Market Share by Type in 2024
Figure 3. OTC
Figure 4. Rx Drugs
Figure 5. Global Central Nervous System Drugs Revenue Market Share by Application in 2024
Figure 6. Hospital
Figure 7. Retail Pharmacy
Figure 8. Global Central Nervous System Drugs Revenue, (USD Million) & (K Units): 2020 & 2024 & 2031
Figure 9. Global Central Nervous System Drugs Revenue and Forecast (2020-2031) & (USD Million)
Figure 10. Global Central Nervous System Drugs Sales (2020-2031) & (K Units)
Figure 11. Global Central Nervous System Drugs Price (2020-2031) & (USD/Unit)
Figure 12. Global Central Nervous System Drugs Production Capacity (2020-2031) & (K Units)
Figure 13. Global Central Nervous System Drugs Production Capacity by Geographic Region: 2024 VS 2031
Figure 14. Central Nervous System Drugs Market Drivers
Figure 15. Central Nervous System Drugs Market Restraints
Figure 16. Central Nervous System Drugs Market Trends
Figure 17. Global Central Nervous System Drugs Sales Market Share by Manufacturer in 2024
Figure 18. Global Central Nervous System Drugs Revenue Market Share by Manufacturer in 2024
Figure 19. Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 20. Top 3 Central Nervous System Drugs Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Central Nervous System Drugs Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Central Nervous System Drugs Sales Market Share by Region (2020-2031)
Figure 23. Global Central Nervous System Drugs Revenue Market Share by Region (2020-2031)
Figure 24. North America Central Nervous System Drugs Revenue (2020-2031) & (USD Million)
Figure 25. Europe Central Nervous System Drugs Revenue (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Central Nervous System Drugs Revenue (2020-2031) & (USD Million)
Figure 27. South America Central Nervous System Drugs Revenue (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Central Nervous System Drugs Revenue (2020-2031) & (USD Million)
Figure 29. Global Central Nervous System Drugs Sales Market Share by Type (2020-2031)
Figure 30. Global Central Nervous System Drugs Revenue Market Share by Type (2020-2031)
Figure 31. Global Central Nervous System Drugs Price by Type (2020-2031) & (USD/Unit)
Figure 32. Global Central Nervous System Drugs Sales Market Share by Application (2020-2031)
Figure 33. Global Central Nervous System Drugs Revenue Market Share by Application (2020-2031)
Figure 34. Global Central Nervous System Drugs Price by Application (2020-2031) & (USD/Unit)
Figure 35. North America Central Nervous System Drugs Sales Market Share by Type (2020-2031)
Figure 36. North America Central Nervous System Drugs Sales Market Share by Application (2020-2031)
Figure 37. North America Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 38. North America Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 39. United States Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 40. Canada Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 41. Mexico Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 42. Europe Central Nervous System Drugs Sales Market Share by Type (2020-2031)
Figure 43. Europe Central Nervous System Drugs Sales Market Share by Application (2020-2031)
Figure 44. Europe Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 45. Europe Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Germany Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 47. France Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 48. United Kingdom Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 49. Russia Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 50. Italy Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Central Nervous System Drugs Sales Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Central Nervous System Drugs Sales Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Central Nervous System Drugs Sales Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Central Nervous System Drugs Revenue Market Share by Region (2020-2031)
Figure 55. China Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 56. Japan Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 57. Korea Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 58. India Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 59. Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 60. Australia Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 61. South America Central Nervous System Drugs Sales Market Share by Type (2020-2031)
Figure 62. South America Central Nervous System Drugs Sales Market Share by Application (2020-2031)
Figure 63. South America Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 64. South America Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 65. Brazil Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 66. Argentina Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Central Nervous System Drugs Sales Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Central Nervous System Drugs Sales Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Central Nervous System Drugs Sales Market Share by Region (2020-2031)
Figure 70. Middle East & Africa Central Nervous System Drugs Revenue Market Share by Region (2020-2031)
Figure 71. Turkey Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 72. Egypt Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 74. South Africa Central Nervous System Drugs Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Central Nervous System Drugs in 2024
Figure 76. Manufacturing Process Analysis of Central Nervous System Drugs
Figure 77. Central Nervous System Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

※参考情報

中枢神経系用治療薬、一般に中枢神経薬と呼ばれるこれらの薬物は、脳および脊髄を含む中枢神経系の疾患や障害に対処するために使用されるものです。中枢神経系は、感覚情報の処理、運動の調整、思考、判断、感情の制御など、人間の基本的な機能を担っており、これに関連した疾患は多岐にわたります。そのため、中枢神経系用治療薬の研究と開発は非常に重要な分野です。

この治療薬の特徴としては、特に脳の神経伝達物質のバランスを調整し、神経細胞の活動を正常化することが挙げられます。神経伝達物質とは、神経細胞間の情報伝達を行う化学物質であり、これらのバランスが崩れると様々な精神的、身体的な障害が引き起こされます。中枢神経系用治療薬は、これらの伝達物質の作用を調整することで、症状を軽減したり治癒を促進したりします。

一般的に、中枢神経系用治療薬は以下のような種類に分類されます。まず、抗うつ薬です。これらはうつ病や不安障害の治療に用いられ、セロトニンやノルエピネフリンなどの神経伝達物質の再取り込みを阻害することで効果を発揮します。代表的なものには、選択的セロトニン再取り込み阻害薬（SSRI）や三環形抗うつ薬などがあります。

次に、抗不安薬が挙げられます。これらの薬剤は、不安やパニック障害などの症状を和らげるために使用されます。ベンゾジアゼピン系薬剤はその代表例であり、神経活動を抑制することで不安を軽減します。

さらに、抗精神病薬も重要です。これらは統合失調症や双極性障害の治療に使用され、ドパミンやセロトニンなどの神経伝達物質の行動を修正します。第二世代の抗精神病薬（非定型抗精神病薬）は、従来の薬剤よりも副作用が少ないとされ、広く用いられています。

これとは別に、抗てんかん薬も中枢神経系用治療薬の一部です。これらは、脳内の異常な神経活動をコントロールすることで、てんかん発作を予防または軽減します。多くの抗てんかん薬があり、発作のタイプや患者の特性に応じて選択されます。

その他には、鎮痛薬や麻酔薬も中枢神経系に直接影響を及ぼす薬剤として位置付けられます。特に、オピオイド系の鎮痛薬は、痛みの信号を脳で処理するメカニズムに介入し、高い鎮痛効果を示しますが、依存性や副作用のリスクも考慮する必要があります。

また、最近では、認知症やアルツハイマー病に関連する治療薬も開発が進んでおり、アセチルコリンエステラーゼ阻害薬などが用いられています。これらの薬は、認知機能の改善や進行の遅延を目的としています。

さらに、中枢神経系用治療薬の関連技術としては、デリバリーシステムやドラッグデリバリー技術が重要です。中枢神経系への薬物の効果を高めるためには、血液脳関門を通過させる必要があります。このため、ナノテクノロジーやリポソーム技術、貼付剤、インプラントなど、多様なアプローチが試みられています。

注射薬や内服薬だけでなく、経皮吸収型の薬物や、点鼻薬としての形態も研究されています。これにより、従来の経口投与に比べて副作用が軽減され、効率的な治療が可能となる可能性があります。

総じて、中枢神経系用治療薬は、脳と脊髄に関連する疾患への治療において極めて重要であり、精神的な健康や身体の機能維持に欠かせないものです。これらの薬剤は、医療現場で広く活用されており、今後も新薬の開発や治療法の改善が期待されます。最新の研究成果や臨床データに基づく新たな知見が、今後の治療に大きな影響を与えることでしょう。中枢神経系の疾患に苦しむ人々にとって、効果的かつ安全な治療薬が提供されることが、より良い生活の質の向上につながります。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 筋骨格系疾患治療薬の世界市場2025年：OTC、Rxドラッグ
  • 血液疾患治療薬の世界市場2025年：OTC、Rxドラッグ
  • 血液学用医薬品の世界市場2025年：OTC、Rxドラッグ
  • 糖代謝異常症治療薬の世界市場2025年：OTC、Rxドラッグ
  • 脂質代謝疾患治療薬の世界市場2025年：OTC、Rxドラッグ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3772 )"中枢神経系用治療薬の世界市場2025年：OTC、Rxドラッグ" (英文：Global Central Nervous System Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。